Volume | 68,675 |
|
|||||
News | - | ||||||
Day High | 6.6864 | Low High |
|||||
Day Low | 6.22 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Metagenomi Inc | MGX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
6.27 | 6.22 | 6.6864 | 6.32 | 6.17 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
906 | 68,675 | US$ 6.41 | US$ 440,365 | - | 5.50 - 12.74 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
16:43:43 | 2 | US$ 6.49 | USD |
Metagenomi Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
237.18M | 37.53M | - | 44.76M | -68.26M | -1.82 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Metagenomi News
Date | Time | Source | News Article |
---|---|---|---|
5/01/2024 | 15:00 | GlobeNewswire Inc. | Metagenomi to regain full development rights to its.. |
4/08/2024 | 07:00 | GlobeNewswire Inc. | Metagenomi to Present at Upcoming Scientific Meetings |
3/27/2024 | 08:16 | GlobeNewswire Inc. | Metagenomi Reports Business Updates and Full Year 2023.. |
2/29/2024 | 15:30 | GlobeNewswire Inc. | Metagenomi to Participate in the 44th Annual Cowen.. |
2/13/2024 | 15:35 | GlobeNewswire Inc. | Metagenomi Announces Closing of Initial Public Offering |
2/08/2024 | 21:16 | GlobeNewswire Inc. | Metagenomi Announces Pricing of Initial Public Offering |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MGX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 6.71 | 8.395 | 5.50 | 6.58 | 284,576 | -0.39 | -5.81% |
1 Month | 10.10 | 10.57 | 5.50 | 7.33 | 161,008 | -3.78 | -37.43% |
3 Months | 10.25 | 12.74 | 5.50 | 10.19 | 202,988 | -3.93 | -38.34% |
6 Months | 10.25 | 12.74 | 5.50 | 10.19 | 202,988 | -3.93 | -38.34% |
1 Year | 10.25 | 12.74 | 5.50 | 10.19 | 202,988 | -3.93 | -38.34% |
3 Years | 10.25 | 12.74 | 5.50 | 10.19 | 202,988 | -3.93 | -38.34% |
5 Years | 10.25 | 12.74 | 5.50 | 10.19 | 202,988 | -3.93 | -38.34% |
Metagenomi Description
At Metagenomi, we are creating potentially curative therapeutics using our metagenomics-powered genome editing toolbox.We believe tools with capabilities that go beyond the current technology landscape will be required in order to reach the full therapeutic potential of genome editing. By harnessing the power of metagenomics, the study of genomes recovered from uncultivated organisms in the natural environment, we are discovering and developing asuite of novel genome editing tools with the potential to make any desired therapeutic gene edit, anywhere in the human genome. |